[go: up one dir, main page]

ES2377796B8 - Procedimiento para preparar productos de terapia celular o ingeniería tisular. - Google Patents

Procedimiento para preparar productos de terapia celular o ingeniería tisular. Download PDF

Info

Publication number
ES2377796B8
ES2377796B8 ES201131906A ES201131906A ES2377796B8 ES 2377796 B8 ES2377796 B8 ES 2377796B8 ES 201131906 A ES201131906 A ES 201131906A ES 201131906 A ES201131906 A ES 201131906A ES 2377796 B8 ES2377796 B8 ES 2377796B8
Authority
ES
Spain
Prior art keywords
procedure
engineering
tissular
cellular therapy
prepare products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201131906A
Other languages
English (en)
Other versions
ES2377796A1 (es
ES2377796B1 (es
Inventor
Pablo Arnau Pla Calvet
Andrés RAYA DONET
Juan García López
Irene Oliver Vila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Banc de Sang i Teixits
Original Assignee
Banc de Sang i Teixits
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banc de Sang i Teixits filed Critical Banc de Sang i Teixits
Priority to ES201131906A priority Critical patent/ES2377796B8/es
Publication of ES2377796A1 publication Critical patent/ES2377796A1/es
Publication of ES2377796B1 publication Critical patent/ES2377796B1/es
Priority to PCT/ES2012/070792 priority patent/WO2013076330A1/es
Application granted granted Critical
Publication of ES2377796B8 publication Critical patent/ES2377796B8/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Procedimiento para preparar productos de terapia celular o ingeniería tisular. Procedimiento de preparación de un producto para terapia celular o ingeniería tisular que comprende las etapas de: a) obtener material celular de un paciente; b) seleccionar la población o poblaciones celulares de interés; c) determinar parámetros de calidad de la población celular seleccionada; d) combinar el material celular obtenido en la etapa (c) con un producto bioactivo; y e) determinar parámetros de calidad del producto obtenido en la etapa (d).
ES201131906A 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular. Expired - Fee Related ES2377796B8 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201131906A ES2377796B8 (es) 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular.
PCT/ES2012/070792 WO2013076330A1 (es) 2011-11-25 2012-11-14 Procedimiento para preparar productos de terapia celular o ingeniería tisular

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201131906A ES2377796B8 (es) 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular.

Publications (3)

Publication Number Publication Date
ES2377796A1 ES2377796A1 (es) 2012-04-02
ES2377796B1 ES2377796B1 (es) 2012-08-13
ES2377796B8 true ES2377796B8 (es) 2012-12-28

Family

ID=45840670

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201131906A Expired - Fee Related ES2377796B8 (es) 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular.

Country Status (2)

Country Link
ES (1) ES2377796B8 (es)
WO (1) WO2013076330A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025396A2 (en) * 1997-11-17 1999-05-27 The Regents Of The University Of Michigan Hybrid tissues for tissue engineering
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
ES2334298B1 (es) * 2007-10-15 2011-01-24 Consejo Superior De Investigaciones Cientificas Constructo util para terapia de regeneracion de tejidos, procedimiento de obtencion y aplicaciones.
JP2012516853A (ja) * 2009-02-04 2012-07-26 エンドジェニター テクノロジーズ，インコーポレイテッド 分化した内皮前駆細胞の治療的使用
EP2422823B1 (en) * 2010-07-30 2014-03-19 Institut Quimic De Sarria Bioactive implant
ES2362021B1 (es) * 2011-05-27 2011-11-24 Banc De Sang I Teixits Procedimiento para la obtención de un producto de ingeniería tisular orientado a la regeneración de tejido cartilaginoso.

Also Published As

Publication number Publication date
ES2377796A1 (es) 2012-04-02
ES2377796B1 (es) 2012-08-13
WO2013076330A1 (es) 2013-05-30

Similar Documents

Publication Publication Date Title
BR112014005752A2 (pt) plataforma para tecidos e órgãos implantáveis produzidos por engenharia tecidual e métodos para sua produção
CO6862129A2 (es) Aparato y proceso para la producción de un producto de células encapsuladas
BR112016019677A2 (pt) método de preparação de um condensado celular in vitro, condensado celular, método de preparação de uma estrutura tissular tridimensional e suporte de cultura semelhante a gel
EP2727521A4 (en) PRODUCT AND METHOD FOR ELECTRONIZING A CLOTH
EP3338818A4 (en) REUSABLE COMPOUND FOR BONE REPAIRS BASED ON AZELLULAR BIOLOGICAL TISSUE MATRIX MATERIAL AND METHOD OF PRODUCTION THEREOF
AR101158A1 (es) Recipiente y método para preparar productos helados o congelados
EP2743269A4 (en) PIM KINASEHEMMER, PROCESS FOR ITS PREPARATION AND ITS USE IN THE DRUG MANUFACTURING
BR112014001655A2 (pt) método de diferenciação de áreas em uma série de n imagens digitais primárias; método para a visualização de populações celulares em uma seção de tecido histológico; e método para a visualização da distribuição tridimensional de múltiplas populações celulares e estruturas celulares dentro do mesmo espaço tridimensional em uma amostra histológica
BR112015018306A2 (pt) tambor e aparelho de formação de alimento, membro poroso, unidade móvel para transportar o tambor, método para trocar um tambor, e métodos para limpar, operar e produzir um aparelho
EP4069821A4 (en) SYSTEM FOR PRODUCING CULTURED MEAT, TISSUES AND RELATED PRODUCTS FROM CELLS
EP2752192A4 (en) PROCESS FOR THE PREPARATION OF A DECELLULARIZED TISSUE PRODUCT, AND GRAFT HAVING A DECELLULARIZED TISSUE PRODUCT
EP2491960A4 (en) COMPOSITION FOR CARTILAGE RANGE AND MANUFACTURING METHOD THEREFOR
CL2013001770A1 (es) Proceso para la fabricacion de productos autoclavado de fibrocemento; y producto autoclavado de fibrocemento.
PL3260865T3 (pl) Sposób obróbki krwi, produktów krwiopochodnych i narządów
SG11202004829WA (en) Method for producing cell mass including pituitary tissue, and cell mass thereof
EP3521417A4 (en) METHOD FOR THE PRODUCTION OF CELL TISSUE AND POROUS FILM
BR112014015232A2 (pt) procedimento para preparar produto alimentício, e, produto alimentício
AP2013007066A0 (en) Polyester-based fiber for artificial hair and ornament product including the same, and method for producing the same
PL4013466T3 (pl) Sposób wytwarzania tkanki chrzęstnej szklistej in vitro
ES2553680B1 (es) Producto comestible de origen animal y procedimiento de fabricación
ES2377796B8 (es) Procedimiento para preparar productos de terapia celular o ingeniería tisular.
EA201590471A1 (ru) Глазированные пищевые продукты с шоколадной сердцевиной и способ их получения
EP3111967A4 (en) High strength synthetic bone for bone replacement for increasing compressive strength and facilitating blood circulation, and manufacturing method therefor
FR2981851B1 (fr) Produit composite, notamment implant medical par exemple bille intraoculaire, et procede de fabrication
BR112014026143A2 (pt) processo para preparação de célula(s)-tronco de leite mamário (bsc) ou um esferoide compreendendo ou consistindo de bsc, célula(s)-tronco de leite mamário (bsc) ou um esferóide compreendendo ou consistindo de bsc, célula(s)-tronco de leite mamário (bsc) isoladas, composição, processo de tratamento da célula em um paciente com necessidade deste, método de tratamento da deficiência de produção de leite em uma lactante fêmea em necessidade deste, e método de tratamento de uma condição de doença em um paciente em necessidade deste

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2377796

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20120813

FD2A Announcement of lapse in spain

Effective date: 20210915